Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Contemporary embolization strategies for active sac management during EVAR.
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
The U.S. FDA has posted several class I recalls in recent days, including a removal of one model of the Medtronic Vascular’s ...
Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
Medtronic has recalled embolization devices collectively linked to reports of 17 injuries and four deaths, the Food and Drug Administration said Tuesday. The recall has two elements: Medtronic is ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's (MDT.N), opens new tab embolization device as "most serious", following reports of the ...
Prostate artery embolization (PAE) is a procedure that helps treat urinary symptoms of an enlarged prostate without a risk of sexual side effects. Generally, both Original Medicare (parts A and B ...